TAOX on Nasdaq
TAO Synergies Inc.
American finance services company based in New York, incorporated in Delaware. Summary from the record
$3.60 up 0.10 (2.86%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 19, 2026.
Overview
Compare with I-ON Digital Corp., SkyAI, Inc. or MedWellAI, Inc., or pick any stock.
- TickerTAOX on Nasdaq1
- IndustryFinance Services1
- HeadquartersNew York, New York1
- Incorporated inDE3
- Business address1185 Avenue Of The Americas, 3Rd Floor, New York, Ny 100363
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formCorporation
See how the biggest companies compare on our leaderboards
From August 23, 2013 to December 6, 2020, Synaptogenix, Inc. (formerly known as Neurotrope Bioscience, Inc.) (the “Company” or “Synaptogenix”) was a wholly owned subsidiary of Neurotrope, Inc. (“Neurotrope”). Neurotrope’s operations were solely those of Synaptogenix. On May 17, 2020, Neurotrope announced plans for the complete legal and structural separation of Synaptogenix from Neurotrope (the “Spin-Off”). Under the Separation and Distribution Agreement between Neurotrope and Synaptogenix (the “Separation and Distribution Agreement”), Neurotrope distributed all of its equity interest in Synaptogenix to Neurotrope’s stockholders. Following the Spin-Off, Neurotrope does not own any equity interest in Synaptogenix, and Synaptogenix operates independently from Neurotrope. On December 6, 2020, Neurotrope approved the final distribution ratio and holders of record of Neurotrope common stock, …4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue11¢$38.3K
- Research and development89¢$322.2K
Out of $299.1K in revenue.5 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues from TAO staking | $299.1K | $0 |
| Research and development | $322.2K | $1.6M |
| General and administrative | $9.0M | $5.2M |
| TOTAL OPERATING EXPENSES | $9.3M | $6.8M |
| OPERATING LOSS | -$9.0M | -$6.8M |
| Interest income | $442.9K | $1.3M |
| Share of net loss in equity investment | -$44.5K | |
| Loss on write-off of available for debt security | -$2.4M | |
| Loss on write-off of equity investment | -$517.9K | |
| Warrant issuance costs | -$1.7M | -$618.4K |
| Unrealized loss on digital assets | -$10.5M | |
| Change in fair value of Yuma partnership investments | -$303.0K | |
| Loss on issuance of Preferred Stock | -$758.7K | -$3.8M |
| Change in fair value of warrant liability | -$12.4M | -$829.0K |
| Change in fair value of derivative liability | $5.6M | $1.0M |
| TOTAL OTHER INCOME | -$19.7M | -$6.0M |
| Net income before income taxes | -$28.7M | -$12.8M |
| Provision for income taxes | $0 | $0 |
| Net income | -$28.7M | -$12.8M |
| Preferred Stock dividends | $338.4K | $789.9K |
| Net income attributable to common stockholders | -$29.1M | -$13.6M |
| Change in fair value of available for sale debt security | $4.8K | |
| Comprehensive loss | -$29.1M | -$13.6M |
| Basic income per common share (in dollars per share) | -$8.81 | -$10.99 |
| Fully diluted income per common share (in dollars per share) | -$8.81 | -$10.99 |
| Basic weighted average common shares outstanding (in shares) | 3.3M shares | 1.2M shares |
| Fully diluted weighted average common shares outstanding (in shares) | 3.3M shares | 1.2M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $5.5M | $17.7M | |
| Digital assets | $17.9M | ||
| Prepaid expenses and other current assets | $2.0M | $64.6K | |
| TOTAL CURRENT ASSETS | $25.4M | $17.7M | |
| Fixed assets, net of accumulated depreciation | $9.3K | $12.9K | |
| Yuma Partnership investments | $447.0K | ||
| TOTAL ASSETS | $25.8M | $17.7M | |
| Accounts payable | $1.2M | $317.3K | |
| Accrued expenses | $638.5K | $697.0K | |
| TOTAL CURRENT LIABILITIES | $1.8M | $1.0M | |
| Warrant liability | $9.0K | $3.8M | |
| Derivative liability | $2.1M | $6.2M | |
| TOTAL LIABILITIES | $3.9M | $11.0M | |
| Common stock - 150,000,000 shares authorized, $0.0001 par value; 7,471,931 shares issued and outstanding as of March 31, 2026 and 7,448,343 shares issued and outstanding as of December 31, 2025. | $746 | $137 | |
| Additional paid-in capital | $97.2M | $53.0M | |
| Accumulated other comprehensive income | $5.7K | $5.7K | |
| Accumulated deficit | -$76.2M | -$47.2M | |
| TOTAL STOCKHOLDERS' EQUITY | $21.1M | $5.9M | $24.3M |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $25.8M | $17.7M | |
| Common stock, shares authorized | 150.0M shares | 150.0M shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares issued (in shares) | 7.4M shares | 1.4M shares | |
| Common stock, shares outstanding (in shares) | 7.4M shares | 1.4M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $5.5M | $17.7M | |
| Digital assets | $17.9M | ||
| Prepaid expenses and other current assets | $2.0M | $64.6K | |
| TOTAL CURRENT ASSETS | $25.4M | $17.7M | |
| Fixed assets, net of accumulated depreciation | $9.3K | $12.9K | |
| Yuma Partnership investments | $447.0K | ||
| TOTAL ASSETS | $25.8M | $17.7M | |
| Accounts payable | $1.2M | $317.3K | |
| Accrued expenses | $638.5K | $697.0K | |
| TOTAL CURRENT LIABILITIES | $1.8M | $1.0M | |
| Warrant liability | $9.0K | $3.8M | |
| Derivative liability | $2.1M | $6.2M | |
| TOTAL LIABILITIES | $3.9M | $11.0M | |
| Common stock - 150,000,000 shares authorized, $0.0001 par value; 7,471,931 shares issued and outstanding as of March 31, 2026 and 7,448,343 shares issued and outstanding as of December 31, 2025. | $746 | $137 | |
| Additional paid-in capital | $97.2M | $53.0M | |
| Accumulated other comprehensive income | $5.7K | $5.7K | |
| Accumulated deficit | -$76.2M | -$47.2M | |
| TOTAL STOCKHOLDERS' EQUITY | $21.1M | $5.9M | $24.3M |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $25.8M | $17.7M | |
| Common stock, shares authorized | 150.0M shares | 150.0M shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares issued (in shares) | 7.4M shares | 1.4M shares | |
| Common stock, shares outstanding (in shares) | 7.4M shares | 1.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income | -$28.7M | -$12.8M |
| Stock based compensation | $1.4M | $25.4K |
| Non-cash revenue from digital assets | -$299.1K | |
| Unrealized loss on digital assets | $10.5M | |
| Change in fair value of Yuma partnership investments | $303.0K | |
| Warrant issuance costs | $1.7M | $618.4K |
| Loss on issuance of Convertible Preferred Stock | $758.7K | $3.8M |
| Change in fair value of warrant liability | $12.4M | $829.0K |
| Change in fair value of derivative liability | -$5.6M | -$1.0M |
| Share of net loss in equity investment | $44.5K | |
| Loss on write-off of available for debt security | $2.4M | |
| Loss on write-off of equity investment | $517.9K | |
| Consulting services paid by issuance of common stock | $118.1K | $118.0K |
| Consulting services paid by issuance of warrants | $573.5K | |
| Depreciation expense | $3.6K | $5.6K |
| Decrease (increase) in prepaid expenses and other current assets | -$379.8K | $368.1K |
| (Decrease) in accounts payable | $858.0K | -$127.3K |
| (Decrease) in accrued expenses | -$58.5K | $261.1K |
| Total adjustments | $22.3M | $7.9M |
| Net Cash Used in Operating Activities | -$6.4M | -$4.9M |
| Purchase of available for sale debt security | -$1.0M | |
| Yuma Partnership investments | -$750.0K | |
| Purchase of crypto currency | -$28.1M | |
| Net Cash Used in Investing Activities | -$28.9M | -$1.0M |
| Proceeds from investor warrant exercises | $10.0M | |
| Dividends on Preferred Stock | -$262.1K | -$950.9K |
| Net Cash Used in Financing Activities | $23.1M | -$5.1M |
| NET DECREASE IN CASH AND EQUIVALENTS | -$12.2M | -$11.0M |
| Issuance of Common Stock for Series B Convertible Preferred Stock installment conversions | $1.4M | |
| Reclassification of warrant liability | $21.4M | |
| Reclassification of derivative liability | $6.4M | |
| Issuance of Consultant Warrants | $2.1M | |
| Change in fair value of available for sale debt security | $4.8K |
No quarter-by-quarter statement was filed.
Leadership
Who has led TAO Synergies Inc., and when. Pick a name to see everywhere that person has worked.
- Chief executive officerAlan J. Tuchman Jun 14, 2021 to Dec 20, 202213
- PresidentDaniel L. Alkon Dec 1, 2022 to Dec 20, 202214
Board members and other officers (7)
- Chief Medical OfficerAlan J. Tuchman Jul 2, 2025 to now15
- Chief Scientific OfficerDaniel L. Alkon Jun 14, 2021 to Dec 1, 202216
- Board memberRobert Ephron Sep 24, 2025 to now17
- Board memberAlan J. Tuchman Jun 14, 2021 to now13
- Board memberDaniel L. Alkon Jun 14, 2021 to Dec 20, 202216
- Board memberJonathan Schechter Jun 14, 2021 to now18
- Board memberWilliam S. Singer Jun 14, 2021 to now19
Named in SEC Form D filings
People the company listed in its private-offering notices.
Former names
Timeline
- Jun 14, 2021New chief executive Alan J. Tuchman becomes CEO13
Filings
173 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 33 major events, 64 insider forms, 6 large holders, 3 private raises, 46 other. The latest 20:
- Oct 9, 2026S-3/A EDGAR
- Aug 13, 202610-Q EDGAR
- Jun 5, 202610-K/A EDGAR
- May 19, 20264 OWNERSHIP DOCUMENT EDGAR
- May 19, 20264 OWNERSHIP DOCUMENT EDGAR
- May 19, 20264 OWNERSHIP DOCUMENT EDGAR
- May 19, 20264 OWNERSHIP DOCUMENT EDGAR
- May 19, 20264 OWNERSHIP DOCUMENT EDGAR
- May 13, 202610-Q EDGAR
- Apr 8, 20264 OWNERSHIP DOCUMENT EDGAR
- Apr 8, 20264 OWNERSHIP DOCUMENT EDGAR
- Apr 8, 20264 OWNERSHIP DOCUMENT EDGAR
- Mar 31, 202610-K EDGAR
- Feb 5, 20265 OWNERSHIP DOCUMENT EDGAR
- Jan 2, 2026S-8 EDGAR
- Jan 2, 2026S-3/A EDGAR
- Dec 19, 20258-K EDGAR
- Nov 21, 2025EFFECT EDGAR
- Nov 19, 2025CORRESP EDGAR
- Nov 17, 2025DEF 14A EDGAR
The 173 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
7 open-market trades by officers, directors and large owners since October 2021: 0 buys and 7 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 16, 2022 | Singer William S.Director | Sale | 27,000 | $1.17 | $31.6K | Form 4 |
| Dec 16, 2022 | WEINSTEIN ROBERTChief Financial Officer | Sale | 27,000 | $1.17 | $31.6K | Form 4 |
| Dec 16, 2022 | Silverman JoshuaExecutive Chairman | Sale | 19,012 | $1.17 | $22.2K | Form 4 |
| Dec 16, 2022 | SCHECHTER JONATHANDirector | Sale | 20,250 | $1.17 | $23.7K | Form 4 |
| Dec 16, 2022 | Alkon Daniel L.President and CSO | Sale | 19,688 | $1.17 | $23.0K | Form 4 |
| Dec 16, 2022 | Bernstein BruceDirector | Sale | 22,500 | $1.17 | $26.3K | Form 4 |
| Dec 16, 2022 | TUCHMAN ALAN JChief Medical Officer | Sale | 27,000 | $1.17 | $31.6K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- INTRACOASTAL CAPITAL, LLCSC 13G/A, 3 filings Feb 11, 2022 to Feb 6, 202421
- HAYWOOD GEORGE WEAVERSC 13G/A, 2 filings Feb 10, 2022 to Jan 18, 202322
- ALPHA CAPITAL ANSTALTSC 13G/A, 1 filing Jan 31, 202223
Money raised
Private offerings the company reported to the SEC on Form D.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 29. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2Yahoo FinanceTAOX quote
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARDaniel L. Alkon, President
- 15
- 16
- 17SEC EDGARRobert Ephron, Board member
- 18SEC EDGARJonathan Schechter, Board member
- 19SEC EDGARWilliam S. Singer, Board member
- 20
- 21
- 22
- 23